XBI icon

SPDR S&P Biotech ETF

732 hedge funds and large institutions have $9.85B invested in SPDR S&P Biotech ETF in 2024 Q4 according to their latest regulatory filings, with 101 funds opening new positions, 193 increasing their positions, 280 reducing their positions, and 115 closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership:

less capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding:

less first-time investments, than exits

New positions opened: | Existing positions closed:

24% less funds holding in top 10

Funds holding in top 10: 2116 (-5)

31% less repeat investments, than reductions

Existing positions increased: 193 | Existing positions reduced: 280

38% less call options, than puts

Call options by funds: $2.07B | Put options by funds: $3.32B

Holders
732
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
16
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.07B
Puts
$3.32B
Net Calls
Net Calls Change

Top Buyers

1 +$799M
2 +$306M
3 +$197M
4
Morgan Stanley
Morgan Stanley
New York
+$194M
5
UBS Group
UBS Group
Switzerland
+$164M
Name Holding Trade Value Shares
Change
Change in
Stake
276
$1.1M
277
$1.09M
278
$1.09M
279
$1.07M
280
$1.06M
281
$1.05M
282
$1.05M
283
$1.04M
284
$1.01M
285
$1.01M
286
$1.01M
287
$988K
288
$981K
289
$979K
290
$968K
291
$966K
292
$962K
293
$953K
294
$939K
295
$934K
296
$925K
297
$921K
298
$911K
299
$908K
300
$906K